Posts by: Jose Marques Lopes, PhD

News, PH News

The first participant has been enrolled in a Phase 2 trial testing the investigational therapy levosimendan in pulmonary hypertension (PH) patients with heart failure and preserved ejection fraction (PH-HFpEF). Ejection ... Read more

March 4, 2019March 4, 2019

Children with IPH Have Similar Transplant Survival Rates as Those with Other Indications, Study Says

News, PH News

Children with idiopathic pulmonary hypertension (IPH) who underwent lung or combined heart-lung transplants show similar survival rates to children who underwent these procedures for other indications, according to a ... Read more

February 21, 2019February 27, 2019

Higher Levels of 2 Autoantibodies Could Help Diagnose CTEPH and PAH, Study Suggests

CTEPH News, News, PAH News

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) have higher serum levels of antibodies against the EDX2 and PHAX proteins, according to research which suggests ... Read more

February 20, 2019February 25, 2019

Balloon Pulmonary Angioplasty Can Shorten CTEPH Patients’ Hospital Stays, Study Reports

CTEPH News, News

Greater experience in balloon pulmonary angioplasty (BPA) enables shorter hospital stays for patients with chronic thromboembolic pulmonary hypertension (CTEPH), reduces use of intensive care, and lowers medical costs while maintaining the ... Read more

February 14, 2019February 20, 2019

Ventavis Improves Right Ventricle Function in Certain PAH Patients, Study Shows

News, PAH News

Acute treatment with Ventavis (iloprost) improves the heart’s right ventricular (RV) function in patients with idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (CTD-PAH), according ... Read more

February 11, 2019February 11, 2019

Wireless Monitoring May Help Transition of Therapy in PAH, Study Suggests

News

An implantable wireless system may help guide the transition from medication administered intravenously — Remodulin (treprostinil) — to one taken orally — Uptravi (selexipag) — in the treatment of pulmonary arterial hypertension (PAH), according ... Read more

January 18, 2019January 28, 2019

PH Linked to Bronchopulmonary Dysplasia Resolves Over Time in Many Preemies, Study Reports

News, PH News

Pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) resolves over time in nearly two-thirds of premature babies, a study shows. However, the findings also revealed that being male, steroid ... Read more

January 16, 2019January 23, 2019

Tracleer May Be More Cost-effective Than Some Other PAH Therapies, Review Study Reports

News, PAH News

Treatment of pulmonary arterial hypertension (PAH) with Tracleer (bosentan) may be more cost-effective than epoprostenol medications or palliative care, but less than Revatio (sildenafil) and other endothelin receptor blockers, ... Read more

January 10, 2019January 21, 2019

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows

News

Treatment with INOpulse for eight weeks is safe and provides clinically meaningful improvements in physical activity in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD), according to ... Read more

January 3, 2019January 11, 2019

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients

CTEPH News, News

Worse measures of blood flow, arterial oxygenation, and cardiac function may underlie the poor clinical condition of chronic thromboembolic pulmonary hypertension (CTEPH) patients who also have obstructive sleep apnea ... Read more

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

1st Participant Enrolled in Phase 2 Trial of Levosimendan for PH Patients with Heart Failure

Children with IPH Have Similar Transplant Survival Rates as Those with Other Indications, Study Says

Higher Levels of 2 Autoantibodies Could Help Diagnose CTEPH and PAH, Study Suggests

Balloon Pulmonary Angioplasty Can Shorten CTEPH Patients’ Hospital Stays, Study Reports

Ventavis Improves Right Ventricle Function in Certain PAH Patients, Study Shows

Wireless Monitoring May Help Transition of Therapy in PAH, Study Suggests

PH Linked to Bronchopulmonary Dysplasia Resolves Over Time in Many Preemies, Study Reports

Tracleer May Be More Cost-effective Than Some Other PAH Therapies, Review Study Reports

INOpulse Device Improves Physical Activity in PH-ILD Patients, Phase 2b Trial Shows

Obstructive Sleep Apnea Affects Cardiac Function of CTEPH Patients

Pin It on Pinterest